Catalyst Wire Dossier Catalyst Wire Dossier

Pertactin-deficient Bordetella pertussis (CHIM challenge agent)

Pertactin-deficient Bordetella pertussis · Dalhousie University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pertactin-deficient Bordetella pertussis (CHIM challenge agent), covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis [Phase 1]

See pricing